MedPath

Shifting of Intrauterine Device and Use of the Menstrual Cup: Case-control Study

Completed
Conditions
Menstrual Cup
Intrauterine Device Migration
Interventions
Other: Questionnaire
Registration Number
NCT04782583
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Brief Summary

In France, 26% of women of childbearing age use an intrauterine device (IUD) containing copper or levonorgestrel as a method of contraception. Failures of IUD contraception are mainly due to shifting or expulsion of the IUD. The risk factors for expulsion of IUDs most often found in the literature are young age (\<25 years), the existence of menorrhagia, dysmenorrhea, being a carrier of a copper IUD rather than a levonorgestrel IUD , a history of IUD expulsion, nulliparity, and an anomaly of the uterine cavity unrecognized (fibroma, adenomyosis).

More and more women are turning to menstrual cups (MCs) as a means of periodic protection. But the use of MC has also been mentioned as a risk factor for IUD expulsion (via a suction effect). In May 2013, reports of displacement, rupture, or even expulsion of copper IUDs in CM users were reported to ANSM.

However, few studies have examined the risks associated with the concomitant use of an MC and an IUD. The data are contradictory and insufficient to provide a clear answer to women. Hence the interest in carrying out a larger prospective study to explore the relationship between IUD expulsion and the use of MC.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
740
Inclusion Criteria
  • Patient aged 18 or over

  • Consultant for one of the following reasons:

    • IUD control
    • IUD expulsion
    • Pregnancy on IUD
    • Other reason that required an ultrasound for the IUD
  • Consent to participate in the study

Exclusion Criteria
  • Patient benefiting from a legal protection measure

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
TEMOINQuestionnaire-
CASQuestionnaire-
Primary Outcome Measures
NameTimeMethod
Evaluating the risk of IUD displacement in patients using menstrual cup1 DAY

Transvaginal ultrasounds will be used to monitor the position of the intrauterine device in patients using a menstrual cup.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

cabinet IPSO

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath